Scarica l'app Stockscreener
1.92
4.35%
0.08
Dopo l'orario di chiusura:
1.92
Precedente Chiudi:
$1.84
Aprire:
$1.85
Volume 24 ore:
2.67M
Relative Volume:
1.63
Capitalizzazione di mercato:
$438.44M
Reddito:
$8.95M
Utile/perdita netta:
$-21.49M
Rapporto P/E:
-16.00
EPS:
-0.12
Flusso di cassa netto:
$-29.24M
1 W Prestazione:
+12.94%
1M Prestazione:
+13.61%
6M Prestazione:
+284.77%
1 anno Prestazione:
+130.96%
Intervallo 1D:
$1.81
$1.95
Intervallo di 1 settimana:
$1.66
$1.95
Portata 52W:
$0.3651
$1.95
Lineage Cell Therapeutics Inc Stock (LCTX) Company Profile
Nome
Lineage Cell Therapeutics Inc
Settore
Industria
Telefono
510-871-4188
Indirizzo
2173 Salk Avenue, Suite 200, Carlsbad, CA
Confronta LCTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LCTX
Lineage Cell Therapeutics Inc
|
1.92 | 420.18M | 8.95M | -21.49M | -29.24M | -0.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lineage Cell Therapeutics Inc Stock (LCTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-20 | Iniziato | Craig Hallum | Buy |
| 2022-11-02 | Iniziato | Robert W. Baird | Outperform |
| 2022-06-14 | Iniziato | B. Riley Securities | Buy |
| 2021-08-19 | Iniziato | Noble Capital Markets | Outperform |
| 2021-03-31 | Iniziato | Cantor Fitzgerald | Overweight |
Lineage Cell Therapeutics Inc Borsa (LCTX) Ultime notizie
How institutional buying supports Lineage Cell Therapeutics Inc. stockBear Alert & Expert Curated Trade Setups - newser.com
Lineage Cell Therapeutics (LCTX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
How to build a custom watchlist for Lineage Cell Therapeutics Inc.Options Play & Risk Controlled Stock Pick Alerts - newser.com
Is Lineage Cell Therapeutics Inc. stock cheap by valuation metrics2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
How Lineage Cell Therapeutics Inc. stock performs during market turbulence2025 Earnings Surprises & Stock Portfolio Risk Control - newser.com
Tools to assess Lineage Cell Therapeutics Inc.’s risk profileEarnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Lineage Cell Therapeutics Hits New 52-Week High of $1.87 - Markets Mojo
Is Lineage Cell Therapeutics Inc. stock undervalued historicallyTrade Performance Summary & Community Verified Watchlist Alerts - newser.com
How Lineage Cell Therapeutics Inc. stock moves on employment data2025 Momentum Check & Smart Money Movement Tracker - newser.com
Published on: 2025-11-02 02:45:07 - newser.com
Can Lineage Cell Therapeutics Inc. rally from current levelsJuly 2025 PostEarnings & High Return Trade Opportunity Guides - newser.com
How Lineage Cell Therapeutics Inc. stock reacts to Fed tightening - newser.com
Is Lineage Cell Therapeutics Inc. stock a top pick in earnings season2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Is Lineage Cell Therapeutics Inc. stock a momentum leaderQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
How hedge fund analytics apply to Lineage Cell Therapeutics Inc. stockPortfolio Gains Summary & Reliable Price Breakout Alerts - newser.com
Will Lineage Cell Therapeutics Inc. stock outperform international peersBear Alert & Growth Focused Investment Plans - newser.com
Regression analysis insights on Lineage Cell Therapeutics Inc. performanceWeekly Market Report & Daily Chart Pattern Signals - newser.com
Why hedge funds are buying Lineage Cell Therapeutics Inc. stockQuarterly Trade Report & Smart Swing Trading Techniques - newser.com
Published on: 2025-11-02 04:56:29 - newser.com
Published on: 2025-11-01 02:10:50 - newser.com
Tools to monitor Lineage Cell Therapeutics Inc. recovery probabilityIPO Watch & Risk Controlled Swing Alerts - newser.com
Lineage Cell Therapeutics to release Q3 2025 results, hosts business update call - Traders Union
Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025 - Business Wire
Published on: 2025-10-30 05:00:08 - newser.com
Published on: 2025-10-29 06:15:34 - newser.com
Published on: 2025-10-29 06:04:11 - newser.com
Published on: 2025-10-29 04:52:09 - newser.com
Lineage Cell Therapeutics Inc Azioni (LCTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):